Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer Indications (THINK)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03018405
Recruitment Status : Recruiting
First Posted : January 12, 2017
Last Update Posted : September 19, 2019
Sponsor:
Information provided by (Responsible Party):
Celyad Oncology SA